alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Brain Inflammation in 9 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis is a rare subtype of autoimmune encephalitis." | 8.31 | Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis. ( Li, J; Lin, J; Wang, J, 2023) |
| "Encephalitis associated with antibodies against alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is an extremely rare type of antibody-mediated encephalitis." | 8.02 | Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis. ( Fan, S; Guan, H; Ren, H; Zhang, Z; Zhou, L, 2021) |
| "Autoimmune encephalitis (AE) associated with autoantibodies against leucine-rich glioma-inactivated protein-1 (LGI1) can present with faciobrachial dystonic seizures (FBDS) and/or limbic encephalitis (LE)." | 4.31 | Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis. ( Bittner, D; Düzel, E; Goihl, A; Korte, M; Körtvélyessy, P; Leypoldt, F; Ludewig, S; Reinhold, D; Rohne, J; Salzburger, L; Schraven, B, 2023) |
| "Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis is a rare subtype of autoimmune encephalitis." | 4.31 | Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis. ( Li, J; Lin, J; Wang, J, 2023) |
| "Encephalitis associated with antibodies against alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is an extremely rare type of antibody-mediated encephalitis." | 4.02 | Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis. ( Fan, S; Guan, H; Ren, H; Zhang, Z; Zhou, L, 2021) |
| "Anti-AMPAR encephalitis is poorly recognized, especially in children, and its clinical phenotype is incompletely described." | 1.72 | Fulminant anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR1 antibodies encephalitis in a Chinese boy: a case report. ( Cheng, M; Han, W; Jiang, L; Ma, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Z | 1 |
| Fan, S | 1 |
| Ren, H | 1 |
| Zhou, L | 1 |
| Guan, H | 1 |
| Han, W | 1 |
| Ma, J | 1 |
| Jiang, L | 1 |
| Cheng, M | 1 |
| Ludewig, S | 1 |
| Salzburger, L | 1 |
| Goihl, A | 1 |
| Rohne, J | 1 |
| Leypoldt, F | 1 |
| Bittner, D | 1 |
| Düzel, E | 1 |
| Schraven, B | 1 |
| Reinhold, D | 1 |
| Korte, M | 1 |
| Körtvélyessy, P | 1 |
| Schäfer, J | 1 |
| Christensen, PB | 1 |
| Jensen, K | 1 |
| Lin, J | 1 |
| Wang, J | 1 |
| Li, J | 1 |
| Joubert, B | 2 |
| Kerschen, P | 1 |
| Zekeridou, A | 1 |
| Desestret, V | 1 |
| Rogemond, V | 1 |
| Chaffois, MO | 1 |
| Ducray, F | 1 |
| Larrue, V | 1 |
| Daubail, B | 1 |
| Idbaih, A | 1 |
| Psimaras, D | 1 |
| Antoine, JC | 1 |
| Delattre, JY | 1 |
| Honnorat, J | 2 |
| Paoletti, P | 1 |
| Avasarala, J | 1 |
| Allan, SM | 1 |
1 review available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Brain Inflammation
| Article | Year |
|---|---|
Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.
Topics: Aged; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Autoimmune Diseases; | 2015 |
8 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Brain Inflammation
| Article | Year |
|---|---|
Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Encephalitis; Humans; Middle Aged; Prognos | 2021 |
Fulminant anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR1 antibodies encephalitis in a Chinese boy: a case report.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Child; China; Encephalitis | 2022 |
Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoantibodies; Encephalitis; Int | 2023 |
AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report.
Topics: Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anti-N-Methyl-D-Aspartate Receptor | 2023 |
Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis.
Topics: Adult; Aged; Aged, 80 and over; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anti-N-Met | 2023 |
Computer-aided Therapeutics in Treating Autoimmune Encephalitis--Reply.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Autoimmune Diseases; Encep | 2016 |
Computer-aided Therapeutics in Treating Autoimmune Encephalitis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Autoimmune Diseases; Encep | 2016 |
Varied actions of proinflammatory cytokines on excitotoxic cell death in the rat central nervous system.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cell Death; Central Nervous Syste | 2002 |